RECURSION PHARMACEUTICALS, INC. (RXRX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $74.68M | +26.9% |
| 2024 | $58.84M | +32.0% |
| 2023 | $44.58M | +11.9% |
| 2022 | $39.84M | +291.5% |
| 2021 | $10.18M | +156.9% |
| 2020 | $3.96M | +70.8% |
| 2019 | $2.32M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $74.68M | +26.9% |
| 2024 | $58.84M | +32.0% |
| 2023 | $44.58M | +11.9% |
| 2022 | $39.84M | +291.5% |
| 2021 | $10.18M | +156.9% |
| 2020 | $3.96M | +70.8% |
| 2019 | $2.32M | — |